SPP1 and chronic obstructive pulmonary disease: Another study demonstrated that inhibition of SPP1 blocked the PIK3C3-AKT-mTOR pathway, resulting in the alleviation of chronic inflammation and mediating Th17/Treg differentiation in chronic obstructive pulmonary disease (COPD) (117) (Figure 2C).